Understanding gene regulation and RNA processing in neurodegenerative diseases
Mechanisms of gene regulation and RNA processing in synucleinopathies
This study is looking at how certain proteins and genes behave in brain cells from people with Lewy body dementia and Parkinson's disease, to better understand how these changes might lead to cell damage and death, which could help find new ways to treat these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10862681 on NIH RePORTER |
What this research studies
This research investigates how gene regulation and RNA processing are affected in neurodegenerative disorders like Lewy body dementia and Parkinson's disease. By studying patient-derived neurons, the researchers aim to identify specific proteins that aggregate due to the accumulation of a-synuclein, a protein linked to these diseases. The study focuses on understanding the role of RNA binding proteins in cellular stress responses and how these changes contribute to cell death. This research employs advanced techniques such as quantitative proteomics and ChIP sequencing to analyze the molecular mechanisms involved.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Lewy body dementia or Parkinson's disease.
Not a fit: Patients with other types of neurodegenerative disorders not related to synucleinopathies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights into the mechanisms of neurodegenerative diseases, potentially paving the way for targeted therapies.
How similar studies have performed: Previous research has shown promising results in understanding protein aggregation in neurodegenerative diseases, indicating that this approach could yield valuable insights.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Mazzulli, Joseph R — Northwestern University at Chicago
- Study coordinator: Mazzulli, Joseph R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.